Neuropathology of variant Creutzfeldt-Jakob disease
- 1 January 2002
- journal article
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Biologies
- Vol. 325 (1) , 27-31
Abstract
The neuropathological features human prion diseases comprise spogiform change, neuronal loss, astrocytic and microglial proliferation and the accumulation of the abnormal isoform of prion protein (PrP RES ) in the central nervous system. Variant Creutzfeldt-Jakob disease (CJD) is a novel human prion disease which appears to result from infection by the bovine spongiform encephalopathy (BSE) agent. The neuropathology of variant CJD shows morphological and immunocytochemical characteristics distinct from all other types of human prion disease, and is characterised by abundant florid and cluster plaques in the cerebrum and cerebellum, and widespread accumulation of PrP RES on immunocytochemistry. Spongiform change is most marked in the caudate nucleus and putamen, and the thalamus exhibits severe neuronal loss and gliosis, which is most marked in the posterior nuclei and correlates with the areas of high signal seen in the posterior thalamus on MRI examination of the brain. Western blot analysis of PrP RES on frozen brain tissue in variant CJD tissue shows a uniform isotype, with a glycoform ratio distinct from sporadic CJD. PrP RES accumulation is widespread in lymphoid tissues in vCJD. All cases of variant CJD are methionine homozygotes at codon 129 of the PrP gene. Histological and biochemical techniques will be required to identify cases of ‘human BSE’ in individuals who are MV or VV at codon 129 of the PrP gene. Continued surveillance is required to investigate this possibility in the UK and other countries where BSE has been reported.Keywords
This publication has 23 references indexed in Scilit:
- Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humansProceedings of the National Academy of Sciences, 1999
- Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samplesThe Lancet, 1999
- Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob diseaseThe Lancet, 1998
- New‐variant Creutzfeldt‐Jakob diseaseNeuropathology, 1998
- Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agentNature, 1997
- The same prion strain causes vCJD and BSENature, 1997
- Prion protein immunocytochemistry – UK five centre consensus reportNeuropathology and Applied Neurobiology, 1997
- Molecular analysis of prion strain variation and the aetiology of 'new variant' CJDNature, 1996
- Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt‐Jakob diseaseNeuropathology and Applied Neurobiology, 1996
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996